Aclaris Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 12:25:57 ET ACRS

Published on 05/07/2026 at 12:25 pm EDT

Aclaris Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 2 million compared to USD 1.46 million a year ago. Net loss was USD 19.82 million compared to USD 15.09 million a year ago.

Basic loss per share from continuing operations was USD 0.15 compared to USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.15 compared to USD 0.12 a year ago.